about
Interventions to increase attendance for diabetic retinopathy screeningThe design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease.The Accuracy and Reliability of Crowdsource Annotations of Digital Retinal ImagesThe small eye phenotype in the EPIC-Norfolk eye study: prevalence and visual impairment in microphthalmos and nanophthalmosSystemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration.Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing.Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study.Clinical Validation of a Smartphone-Based Adapter for Optic Disc Imaging in Kenya.Nigeria normative data for defining glaucoma in prevalence surveys.What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration?Crowdsourcing as a novel technique for retinal fundus photography classification: analysis of images in the EPIC Norfolk cohort on behalf of the UK Biobank Eye and Vision Consortium.Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia.A smartphone based ophthalmoscope.A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.Agreement between image grading of conventional (45°) and ultra wide-angle (200°) digital images in the macula in the Reykjavik eye study.Noninvasive Retinal Markers in Diabetic Retinopathy: Advancing from Bench towards BedsideThe Nakuru eye disease cohort study: methodology & rationale.Macular thickness in healthy eyes of adults (N = 4508) and relation to sex, age and refraction: the Tromsø Eye Study (2007-2008).Comparison of image-assisted versus traditional fundus examination.Cone photoreceptor definition on adaptive optics retinal imaging.Barriers to sight impairment certification in the UK: the example of a population with diabetes in East London.Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.Macular telangiectasia type 2.Identification of a potential susceptibility locus for macular telangiectasia type 2.Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trialThe National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV?Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study.Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5).The reading of components of diabetic retinopathy: an evolutionary approach for filtering normal digital fundus imaging in screening and population based studies.Tear fluid proteomics multimarkers for diabetic retinopathy screening.Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4).Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey.A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study).Prevalence and correlates of diabetic retinopathy in a population-based survey of older people in Nakuru, Kenya.Area deprivation and age related macular degeneration in the EPIC-Norfolk Eye Study.The ophthalmic branch of the Gutenberg Health Study: study design, cohort profile and self-reported diseasesWide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.
P50
Q24186687-BA51D610-FFBB-49DA-933B-39BAA0298062Q27324293-25C40AE3-1E67-4C20-A655-D816E4289FC1Q27334370-F762B2C5-A9B6-42D4-84C3-D89723D5CE5DQ28689534-9CD38D68-EBE6-40C9-915E-C69A1D1FB451Q30234417-054F5482-AD80-430A-A84B-5AB65F26412AQ30243976-9DF82120-56E7-4C79-AF09-FFE42C7FE448Q30832269-1E57F10B-C90D-485B-8BA9-4D329C12D49FQ30839618-006B3BEC-9B5C-4DF1-BB0C-4748132D92BEQ30911129-19D1FFBD-6CCF-43D7-AD8B-0A147FAA8EFBQ31034870-0431CBD6-8042-414B-8A69-FAC96D2431BBQ31131155-A6121137-93D5-4856-90C9-411D76110EFBQ33323268-248BE4F2-AC48-4C80-BD49-72F357F04AB9Q33442447-F955EAE6-421E-4176-ACD4-C302BA57BF58Q33563565-0A54A5FB-E113-49AF-ABD0-2B1C447159A1Q33593801-65D2FAEC-7271-4F36-B77C-751ED518C8A1Q33608021-767F8ED7-5DCF-44C4-A03F-DBACD490C2CFQ33624678-9ED1AFB6-D9F5-40F4-947B-A3924EA5F239Q33626208-FF454720-0A87-415A-B574-74404AAA8035Q33688177-EB5F4F3B-756F-4434-AA97-9E1712C7A559Q33956468-D2E752D5-6D59-4E28-B02E-9B3F2CAD3EE7Q34106527-429F49FD-0A5C-4385-BAA3-49DCEFE533DCQ34164115-A98E1C8E-F6DC-41B1-8318-5B9933ABA4CCQ34227470-3946B9BA-E8B8-4A48-88B3-72C7ABE6B570Q34316044-2F15879A-5EE9-49B9-8949-4F0ADDDD27C7Q34404580-394DACE0-3FE0-4B5A-9AE7-4A8499AF2686Q34454997-5C386757-6D25-4C4F-AD12-B91DF64F045EQ34492469-001C97B8-247D-4D47-BA85-D59D6CB1911EQ34498235-45923716-927F-46DA-B233-E59186FDFED6Q34516572-B85EB636-E019-4E17-B314-7E0CFD6152BEQ34594919-EB6B6C19-3CD5-472E-BC6B-7CB8AF53A00DQ34792137-9C2A83FA-C92F-4412-952E-47F2C7B19F71Q34808929-D009CB81-6EBC-4CC2-A3FC-A103B53FD5EFQ34898877-EF7B8EA8-4AAE-4CB3-89FF-BC3398F109DFQ34980970-DD20B262-AEC6-4578-BA54-B721274E546AQ34992483-837CFB9B-3019-4C9E-BF19-CB4DC2147A8FQ35094974-1BEA3690-19AE-41C2-98E7-D07DE0EC14EBQ35155654-A9D5B206-1D65-474F-AD95-058F49DC1619Q35170813-9532BD0C-EE5B-491B-B96A-6789F66DA0BDQ35182480-5574E91E-DA09-4929-AF67-F730CFC596C4Q35196884-36561083-6FB2-46DA-9D2A-1C3B7117F11F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tunde Peto
@ast
Tunde Peto
@en
Tunde Peto
@es
Tunde Peto
@nl
Tunde Peto
@sl
type
label
Tunde Peto
@ast
Tunde Peto
@en
Tunde Peto
@es
Tunde Peto
@nl
Tunde Peto
@sl
prefLabel
Tunde Peto
@ast
Tunde Peto
@en
Tunde Peto
@es
Tunde Peto
@nl
Tunde Peto
@sl
P106
P21
P31
P496
0000-0001-6265-0381